Regenxbio (RGNX) Tax Provisions (2018 - 2022)

Regenxbio's Tax Provisions history runs 5 years deep, the most recent figure standing at -$43000.0 for Q4 2022.

• In Q4 2022, Tax Provisions fell 100.32% year-over-year to -$43000.0; the TTM figure through Dec 2022 stood at -$84000.0 (down 100.63% YoY), while the FY2023 annual figure was -$152000.0, down 80.95% from the prior year.
• Tax Provisions was -$43000.0 for Q4 2022 at Regenxbio, down from -$41000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $13.4 million in Q4 2021 to a low of -$2.4 million in Q4 2019.
• Historically, Tax Provisions has averaged $1.4 million across 5 years, with a median of -$22000.0 in 2020.
• The sharpest annual moves came in 2020 and 2022: Tax Provisions soared 340.19% in 2020, then sank 1125.0% in 2022.
• A 5-year view of Tax Provisions shows it stood at $1.6 million in 2018, then plunged by 247.5% to -$2.4 million in 2019, then jumped by 340.19% to $5.7 million in 2020, then jumped by 133.38% to $13.4 million in 2021, then slumped by 100.32% to -$43000.0 in 2022.
• The last three Tax Provisions figures came in at -$43000.0 (Q4 2022), -$41000.0 (Q1 2022), and $13.4 million (Q4 2021), per Business Quant data.